Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.69+0.01 (+2.10%)
Close on Nov 18, 2026Market cap $8.09MP/E –Yield –
Radiopharm Theranostics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2026 it was $2.77M, down 23.8% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $2.77M | -23.8% |
| FY2025 | Jun 30, 2025 | $3.63M | +1114.3% |
| FY2024 | Jun 30, 2024 | $299.23K | +2.3% |
| FY2023 | Jun 30, 2023 | $292.36K | – |
See a number that looks wrong?